怀化微信怎么查询做鸡的微信-怀化微信怎么查询做鸡的微信_主页

在临沧酒店晚上怎么叫服务

Welcome to the official website of Yantai Dongcheng Pharmaceutical Group Co., Ltd!
Stock Code: 002675
Honor of Dongcheng
Your current position: home page >> About Dongcheng >>Honor of Dongcheng
  two thousand and nineteen
two thousand and nineteen year two The company won the Yantai Economic and Technological Development Zone two thousand and eighteen The second prize of outstanding enterprise fulfilling social responsibility
two thousand and nineteen year three In January, nadroparin calcium raw material and nadroparin calcium for injection were awarded the "Yantai pharmaceutical and medical device innovation product award plan", with a total of prizes two hundred and thirty-two point nine Ten thousand yuan.
two thousand and nineteen year six In June, the company was announced as a technological innovation demonstration enterprise in Shandong Province.
two thousand and nineteen year six In June, the company was listed as a high-quality supplier and partner in the international market sixty Strong.
two thousand and nineteen year seven In June, the company was honored two thousand and eighteen The annual Top 100 list of China's pharmaceutical industry is the top 100 pharmaceutical enterprises in China.
 
 2018
two thousand and eighteen year one In June, the company was successfully selected into Yantai Industrial "double" fifty "Enterprise" leading enterprise
two thousand and eighteen year two The company was awarded "Yantai City" two thousand and seventeen Enterprises with outstanding achievements in economic development of the year Yantai Economic and Technological Development Zone two thousand and seventeen The second prize of outstanding enterprise fulfilling social responsibility "Yantai biomedical comprehensive strength top 10 enterprises" and "Yantai biomedical international development top 10 enterprises" and other honorary titles.
two thousand and eighteen year six In January, nadroparin calcium raw material and nadroparin calcium for injection were awarded the "Yantai pharmaceutical and medical device innovation product award plan", with a total of funds three hundred and ten Million.
two thousand and eighteen year seven In June, the company was shortlisted for the first time“ two thousand and seventeen China's top 100 pharmaceutical industry of the year.
two thousand and eighteen year nine Rongyue company two thousand and eighteen Top 100 enterprise brand value in Shandong Province
two thousand and eighteen year eleven In June, the company was awarded the title of "Yantai key independent export brand" by Yantai Municipal Bureau of Commerce.
two thousand and eighteen year twelve In June, nadroparin calcium bailishu won the "excellent brand of Chinese biochemical and biological drugs".
 
  two thousand and seventeen
In February 2017, the company was awarded the title of "2016 outstanding corporate social responsibility Award"
In December 2017, chondroitin sulfate was awarded the title of "excellent brand of biochemical and biological drugs in 2017" by China biochemical pharmaceutical industry association
In December 2017, the company was awarded the top 100 enterprise brand value of Shandong Province in 2017
In June 2017, Yunke Pharmaceutical Co., Ltd. "industrialization of iodine [125I] sealed seed source for new targeted interventional therapy of solid tumor" was listed as "demonstration project of major scientific and technological achievements transformation project in Sichuan Province"
In August 2017, the technical center of Yunke Pharmaceutical Co., Ltd. was recognized as "Sichuan enterprise technology center"
 
  two thousand and sixteen
In August 2016, the company was awarded "Yantai pharmaceutical innovation contribution unit"
In March 2016, the subsidiary Dongcheng Dayang "ten tastes gout provincial innovation fund project" successfully passed the acceptance
In January 2016, Yunke pharmaceutical was awarded the honorary title of "Chengdu enterprise technology center"
In January 2016, the subsidiary Dongcheng Dayang was awarded the "2015 advanced unit of work safety"

  two thousand and fifteen
In April 2015, it was awarded the second prize of social responsibility of Yantai Development Zone
In April 2015, the company was awarded the title of "innovation model studio of Dayangshan"
In May 2015, the company's biopolysaccharide drug engineering laboratory was recognized as a provincial engineering laboratory by Shandong Provincial Development and Reform Commission
In November 2015, the company was recognized as "Shandong marine biological new drug Engineering Technology Collaborative Innovation Center"
 
  two thousand and fourteen
In February 2014, it was awarded the title of "2013 excellent enterprise for fulfilling social responsibility"
In February 2014, it was awarded the title of "2013 advanced collective of work safety"
In February 2014, the subsidiary Dayang pharmaceutical was awarded the title of "2013 star enterprise" in Fushan District
In June 2014, Dongcheng biochemical was awarded the title of "Yantai city's outstanding enterprise in opening up"
In September 2014, heparin sodium and chondroitin sulfate obtained bgv GMP certificate in Hamburg, Germany

two thousand and thirteen
2013 is Dongcheng's 15th birthday. All Dongcheng people will present Dongcheng's 15th anniversary with outstanding achievements and honors
On January 20, 2013, the company officially signed the strategic cooperation framework agreement of "R & D project of new drug resistant antibiotics" with the Institute of drug research of Chinese Academy of Medical Sciences
In June 2013, the project of "research and development and industrialization of new anticoagulant drug HT-1 API and injection" was included in the major independent innovation project of Shandong Province
Shandong Xingtai science and Technology Co., Ltd. is recognized as "Shandong Xingtai science and Technology Co., Ltd."
In July 2013, the "industrialization of low titer heparin sodium" project was recognized as a common technology R & D project of electromechanical and high-tech products by Shandong Provincial Department of Commerce
In August 2013, the "new antifungal drug R & D center" jointly established by the company, Shanghai Second Military Medical University and Yantai Economic and Technological Development Zone Management Committee was officially unveiled
In September 2013, the technical center of Yantai Dongcheng Biochemical Co., Ltd. was recognized as "Yantai biopolysaccharide drug Engineering Laboratory" by Yantai Municipal Development and Reform Commission
In October 2013, the two sub projects of new drug creation of national major special project of drug incubation base - "transformation and expansion of heparin production technology" and "research and development of SP-10, a class of new drug", passed the financial acceptance in Shandong Province
"Shandong chemical synthesis oligosaccharide drug engineering technology research center" in November 2013

two thousand and twelve
In May 2012, Dongcheng biochemical A-share was listed, reaching a new historical starting point
In 2012, heparin sodium and chondroitin sulfate passed the national CFDA 2010 version of GMP certification

two thousand and eleven
In 2011, chondroitin sulfate and heparin sodium passed the official GMP certification of bgv in Hamburg, Germany
In 2011, heparin sodium passed PMDA GMP certification in Japan

two thousand and ten
In May 2010, some products of chondroitin obtained the registration certificate of CEP and some products of chondroitin obtained the certificate of CEP in May 2010

two thousand and nine
In 2009, heparin sodium products passed the U.S. FDA audit of zero 483 defect; heparin sodium passed the KFDA GMP certification of Korea

two thousand and eight
In 2008, the company registered with the FDA for the third time, and Fenjin finished its third GMP audit in the United States in November 2008

two thousand and seven
In 2007, the company completed the joint-stock reform, and Dongcheng Biochemical Co., Ltd. officially changed its name to Dongcheng Biochemical Co., Ltd. And successively completed the registration of heparin like products in MF of Japan's Ministry of health, the GMP audit of German Hamburg health authorities for heparin sodium products and chondroitin sulfate, and the registration of foreign manufacturers of drugs of Japan's Ministry of health and welfare.

two thousand and six
In January 2006, chondroitin sulfate products were registered with MF of the Ministry of health and welfare of Japan. In March, chondroitin sulfate products passed the on-site audit of usp-dsvp of the United States, and was authorized to use USP label on the packaging barrel. Dongcheng biochemical industry became the first chondroitin sulfate factory in the world to obtain the label. In August, heparin sodium and small molecular weight heparin sodium completed the MF registration of Japan's Ministry of health and welfare. In August of the same year, Dongyuan Bioengineering Co., Ltd. started construction in Yinan County, Shandong Province, and became a base for the company to improve its industrial chain and develop new biochemical products.

two thousand and five
In 2005, it became the first pharmaceutical enterprise in China to obtain cos certificate issued by European Union EDQM, and obtained FDA certification for heparin sodium products and registration certificate for small molecular heparin sodium products in India

two thousand and four
In 2004, heparin sodium products successively obtained the Russian registration certificate and GMP audit of German Hamburg Health Authority

two thousand and three
In 2003, chondroitin sulfate was registered in DMF of FDA in USA and heparin sodium was registered in India

two thousand and one
In 2001, it passed the ISO9001 certification approved by DET Norske Veritas

two thousand
In 2000, it passed the GMP certification approved by the State Food and drug administration, and became the first biochemical API enterprise to pass the certification in China

one thousand nine hundred and ninety-eight
In 1998, Dongcheng biochemical entered Yantai Development Zone, opening a new chapter in China's biochemical pharmaceutical industry
 

 

contact us CONTACT US
0535-6391521
Switchboard: 86-535-6391521 / 6391522
Email: zxu @ midatlanticlegends.com
Address: No.7 Changbaishan Road, Yantai Development Zone, Shandong Province
Copyright 2014 Yantai Dongcheng Pharmaceutical Group Co., Ltd. All Rights Reserved Lu ICP Bei 18035060-1